|
|
|
|
|
|
|
|
|
|
 
|
|
|
|
Biobank
invests in life sciences companies on a worldwide basis that combine:
a strong intellectual property position, committed founders and near term
product opportunities with competitive and strategic advantages and well
defined milestones.
|
|
|
|
|
|
|
|
The
Biobank philosophy is to identify and combine the highest quality
technology, talent and capital on a global basis. We use these assets to
create lean and flexible organizations that can thrive and grow in the new
global economy. The Biobank operating philosophy provides our venture
companies with the ability to focus their efforts on bringing new products,
technologies and ideas to market; Biobank takes care of the rest. We
believe that our operating model offers significant advantages with respect
to lowering the cost of capital and accelerating the time to market of new
products. We identify the opportunity, assemble the pieces, structure the
company, support its activities and create a road map for its success.
|
|
|
|
|
|
|
|
|
|
|
|
 Stell . La Jolla, CA
Sangamo BioSciences . Richmond, CA
|
|
Focus: knock-out cells for human
therapy
Technology: zinc finger endonucleases
Headquarters: Richmond, California
Partners: Karolinska Institute
Founders: Monika Liljedahl, MD, Ph.D., Simon Aspland, Ph.D.
Stell has merged
with Sangamo BioSciences
www.sangamo.com
|
|
|
|
|
|
|
|
EGeen . Mountain View, CA
|
|
Focus: clinical research and
pharmacogenetics
Technology: clinical and genomics data collection and mining
Headquarters: Mountain View, California
Partner: Estonian Gene Bank Project
Founders: Andres Metspalu, MD, Ph.D., Kalev Kask, Ph.D., Jaanus
Pikani, MD
www.egeeninc.com
|
|
|
|
